Jui-Wen Huang

1.4k total citations
19 papers, 1.2k citations indexed

About

Jui-Wen Huang is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Jui-Wen Huang has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Jui-Wen Huang's work include Protein Tyrosine Phosphatases (7 papers), Cancer Mechanisms and Therapy (5 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Jui-Wen Huang is often cited by papers focused on Protein Tyrosine Phosphatases (7 papers), Cancer Mechanisms and Therapy (5 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Jui-Wen Huang collaborates with scholars based in Taiwan, United States and South Korea. Jui-Wen Huang's co-authors include Chung-Wai Shiau, Kuen‐Feng Chen, Ching-Shih Chen, Samuel K. Kulp, Wei‐Tien Tai, Chih-Cheng Yang, Pei‐Jer Chen, Ya-Ting Yang, Chun‐Yu Liu and Hsiang–Po Huang and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Hepatology.

In The Last Decade

Jui-Wen Huang

19 papers receiving 1.2k citations

Peers

Countries citing papers authored by Jui-Wen Huang

Since Specialization

Citations

This map shows the geographic impact of Jui-Wen Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jui-Wen Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jui-Wen Huang more than expected).

Fields of papers citing papers by Jui-Wen Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jui-Wen Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jui-Wen Huang. The network helps show where Jui-Wen Huang may publish in the future.

Co-authorship network of co-authors of Jui-Wen Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Jui-Wen Huang. A scholar is included among the top collaborators of Jui-Wen Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jui-Wen Huang. Jui-Wen Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Protein tyrosine phosphatase 1B targets PITX1/p120RasGAP thus showing therapeutic potential in colorectal carcinoma 2016 ·Scientific Reports ·Hao‐Wei Teng, Man‐Hsin Hung, (unknown), (unknown), (unknown), Ming‐Hsien Tsai, Jui-Wen Huang, Chih-Lung Lin, Hsiang‐Wen Tseng, (unknown), Jeng‐Kai Jiang, Shung-Haur Yang, Chung-Wai Shiau, Kuen‐Feng Chen	10
2	Copper–obatoclax derivative complexes mediate DNA cleavage and exhibit anti-cancer effects in hepatocellular carcinoma 2015 ·Chemico-Biological Interactions ·Jung-Chen Su, (unknown), Jui-Wen Huang, Ping‐Yu Chen, Kuen‐Feng Chen, Ping‐Hui Tseng, Chung-Wai Shiau	6
3	A Porphodimethene Chemical Inhibitor of Uroporphyrinogen Decarboxylase 2014 ·PLoS ONE ·Kenneth W. Yip, Zhan Zhang, (unknown), Jui-Wen Huang, (unknown), (unknown), Chih‐Lung Lin, Jennifer Kwan, Shi‐Jun Yue, Yulia Jitkova, (unknown), Payam Zahedi, E.F. Pai, Aaron D. Schimmer, Jonathan F. Lovell, Jonathan L. Sessler, Fei‐Fei Liu	3
4	Nintedanib (BIBF-1120) inhibits hepatocellular carcinoma growth independent of angiokinase activity 2014 ·Journal of Hepatology ·Wei‐Tien Tai, Chung-Wai Shiau, (unknown), Chun-Wei Chang, Jui-Wen Huang, (unknown), (unknown), Kuen‐Feng Chen	32
5	RFX1-dependent activation of SHP-1 induces autophagy by a novel obatoclax derivative in hepatocellular carcinoma cells 2014 ·Oncotarget ·Jung-Chen Su, Ping‐Hui Tseng, (unknown), Wei‐Tien Tai, Jui-Wen Huang, Ching-Huai Ko, (unknown), Chun‐Yu Liu, Kuen‐Feng Chen, Chung-Wai Shiau	25
6	SHP-1 is a target of regorafenib in colorectal cancer 2014 ·Oncotarget ·(unknown), Hao‐Wei Teng, Chung-Wai Shiau, Hang Lin, Man‐Hsin Hung, Yen‐Lin Chen, Jui-Wen Huang, Wei‐Tien Tai, (unknown), Kuen‐Feng Chen	46
7	SC-60, a Dimer-Based Sorafenib Derivative, Shows a Better Anti–Hepatocellular Carcinoma Effect than Sorafenib in a Preclinical Hepatocellular Carcinoma Model 2013 ·Molecular Cancer Therapeutics ·Wei‐Tien Tai, Chung-Wai Shiau, (unknown), Yao-Li Chen, Pei‐Yi Chu, Jui-Wen Huang, (unknown), (unknown), Pei‐Jer Chen, Kuen‐Feng Chen	7
8	Discovery of novel src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma 2013 ·Hepatology ·Wei‐Tien Tai, Chung-Wai Shiau, Pei‐Jer Chen, Pei‐Yi Chu, Hsiang–Po Huang, Chun‐Yu Liu, Jui-Wen Huang, Kuen‐Feng Chen	66
9	A novel obatoclax derivative, SC-2001, induces apoptosis in hepatocellular carcinoma cells through SHP-1-dependent STAT3 inactivation 2012 ·Cancer Letters ·Kuen‐Feng Chen, Jung-Chen Su, Chun‐Yu Liu, Jui-Wen Huang, (unknown), (unknown), Wei‐Tien Tai, Chung-Wai Shiau	44
10	Development of erlotinib derivatives as CIP2A-ablating agents independent of EGFR activity 2012 ·Bioorganic & Medicinal Chemistry ·Kuen‐Feng Chen, (unknown), Jung-Chen Su, (unknown), Chun‐Yu Liu, Hui-Ju Chen, Jui-Wen Huang, Inki Kim, Chung-Wai Shiau	35
11	Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity 2012 ·European Journal of Medicinal Chemistry ·Kuen‐Feng Chen, Wei‐Tien Tai, (unknown), Jui-Wen Huang, Chun‐Yu Liu, Pei‐Jer Chen, Inki Kim, Chung-Wai Shiau	73
12	Pharmacophore modeling and virtual screening to identify potential RET kinase inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Chung-Wai Shiau, (unknown), Ching-Huai Ko, Chih-Lung Lin, Chun‐Yuan Lin, (unknown), Chuan-Yi Tang, (unknown), Jui-Wen Huang	13
13	Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma 2011 ·Journal of Hepatology ·Wei‐Tien Tai, Ann‐Lii Cheng, Chung-Wai Shiau, Hsiang–Po Huang, Jui-Wen Huang, Pei‐Jer Chen, Kuen‐Feng Chen	141
14	Fragment-Based Design of Small Molecule X-Linked Inhibitor of Apoptosis Protein Inhibitors 2008 ·Journal of Medicinal Chemistry ·Jui-Wen Huang, Ziming Zhang, Bainan Wu, Jason Cellitti, Xiyun Zhang, Russell Dahl, Chung-Wai Shiau, Kate Welsh, Aras Emdadi, John L. Stebbins, John C. Reed, Maurizio Pellecchia	43
15	α-Tocopheryl Succinate Induces Apoptosis in Prostate Cancer Cells in Part through Inhibition of Bcl-xL/Bcl-2 Function 2006 ·Journal of Biological Chemistry ·Chung-Wai Shiau, Jui-Wen Huang, Da-Sheng Wang, Jing‐Ru Weng, Chih-Cheng Yang, Chia‐Hui Lin, Chenglong Li, Ching-Shih Chen	95
16	Development of Small-Molecule Cyclin D1-Ablative Agents 2006 ·Journal of Medicinal Chemistry ·Jui-Wen Huang, Chung-Wai Shiau, Jian Yang, Da-Sheng Wang, Hao‐Chieh Chiu, Ching‐Yu Chen, Ching-Shih Chen	45
17	Peroxisome Proliferator-Activated Receptor γ-Independent Ablation of Cyclin D1 by Thiazolidinediones and Their Derivatives in Breast Cancer Cells 2005 ·Molecular Pharmacology ·Jui-Wen Huang, Chung-Wai Shiau, Ya-Ting Yang, Samuel K. Kulp, Kuen‐Feng Chen, Robert W. Brueggemeier, Charles L. Shapiro, Ching-Shih Chen	107
18	Thiazolidenediones Mediate Apoptosis in Prostate Cancer Cells in Part through Inhibition of Bcl-xL/Bcl-2 Functions Independently of PPARγ 2005 ·Cancer Research ·Chung-Wai Shiau, Chih-Cheng Yang, Samuel K. Kulp, Kuen‐Feng Chen, Chang‐Shi Chen, Jui-Wen Huang, Ching-Shih Chen	192
19	From the Cyclooxygenase-2 Inhibitor Celecoxib to a Novel Class of 3-Phosphoinositide-Dependent Protein Kinase-1 Inhibitors 2004 ·Cancer Research ·Jiuxiang Zhu, Jui-Wen Huang, Ping‐Hui Tseng, Ya-Ting Yang, Joseph Fowble, Chung-Wai Shiau, (unknown), Samuel K. Kulp, Ching-Shih Chen	215

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact